![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/shareholding/getty_681735120_359777.jpg)
Share the post "Mutual Fund Deals : Onesource Specialty Pharma Lim on 31 Jan"
Dive into our extensive analysis of recent mutual fund deals to understand the strategic movements of top-tier mutual funds. This report covers significant transactions that outline the evolving tactics of fund managers in response to market dynamics. These deals not only signify substantial capital shifts but also highlight trends in institutional investment that could forecast future market behavior. By keeping abreast of these critical changes, investors can adjust their strategies to capitalize on emerging opportunities and safeguard against potential downturns, thereby optimizing their investment outcomes. We present a summary of the latest transactions and trends within the mutual fund for our clients: Motilal Oswal Mutual Fund A/c Motilal Oswal Large And Midcap Fund. Join us as we explore these details further in the sections below.
1M shares have been purchased by Motilal Oswal Mutual Fund A/c Motilal Oswal Large And Midcap Fund through mutual funds at a price of ₹1545.00 per share, and it is sold by Tenshi Pharmaceuticals Private at a price of ₹1545.00 per share. Recent activity in the mutual fund data shows Motilal Oswal Mutual Fund A/c Motilal Oswal Large And Midcap Fund’s transaction with Onesource Specialty Pharma Lim shares, marking a key adjustment in their investment approach, which could influence broader market perceptions.
Recent Bulk Deals:
| Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|
| Motilal Oswal Mutual Fund A/c Motilal Oswal Large And Midcap Fund | Buy | 1M | 1545.00 | Tenshi Pharmaceuticals Private |
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/GULFOILLUB.png)
